Sumitomo Dainippon Pharma Co Ltd (4506) - Financial and Strategic SWOT Analysis Review
Sumitomo Dainippon Pharma Co Ltd (4506) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Sumitomo Dainippon Pharma Co Ltd (Sumitomo Dainippon), a subsidiary of Sumitomo Chemical Co Ltd develops, manufactures, sells, imports and exports pharmaceutical products. The company drugs are focused on major therapeutic areas which include regenerative diseases, oncology, psychiatry and neurology and infectious diseases. It also offers veterinary products, food additives, chemical product materials, food ingredients, cosmetic materials and other products. Sumitomo Dainippon has research laboratories, manufacturing and distribution facilities in Japan. The company operates through subsidiaries and offices in the North America, Europe and Asia Pacific. Sumitomo Dainippon is headquartered in Chuo-ku, Osaka, Japan.
Sumitomo Dainippon Pharma Co Ltd Key Recent Developments
May 12,2021: Sumitomo Dainippon Pharma Notice of Change of Trade Name and Partial Amendment to Articles of Incorporation
Mar 05,2021: Sumitomo Dainippon Pharma announces posting of Impairment Loss
Mar 04,2021: Sumitomo Dainippon Pharma earns recognition for the first time in the health & productivity management stock selection
Mar 02,2021: Sumitomo Dainippon Pharma announces organizational realignment and changes in the positions assumed by executive officers and other key positions
Feb 26,2021: Sumitomo Dainippon Pharma announces changes of Representative Directors and Executive Officers
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Sumitomo Dainippon Pharma Co Ltd (Sumitomo Dainippon), a subsidiary of Sumitomo Chemical Co Ltd develops, manufactures, sells, imports and exports pharmaceutical products. The company drugs are focused on major therapeutic areas which include regenerative diseases, oncology, psychiatry and neurology and infectious diseases. It also offers veterinary products, food additives, chemical product materials, food ingredients, cosmetic materials and other products. Sumitomo Dainippon has research laboratories, manufacturing and distribution facilities in Japan. The company operates through subsidiaries and offices in the North America, Europe and Asia Pacific. Sumitomo Dainippon is headquartered in Chuo-ku, Osaka, Japan.
Sumitomo Dainippon Pharma Co Ltd Key Recent Developments
May 12,2021: Sumitomo Dainippon Pharma Notice of Change of Trade Name and Partial Amendment to Articles of Incorporation
Mar 05,2021: Sumitomo Dainippon Pharma announces posting of Impairment Loss
Mar 04,2021: Sumitomo Dainippon Pharma earns recognition for the first time in the health & productivity management stock selection
Mar 02,2021: Sumitomo Dainippon Pharma announces organizational realignment and changes in the positions assumed by executive officers and other key positions
Feb 26,2021: Sumitomo Dainippon Pharma announces changes of Representative Directors and Executive Officers
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Sumitomo Dainippon Pharma Co Ltd - Key Facts
Sumitomo Dainippon Pharma Co Ltd - Key Employees
Sumitomo Dainippon Pharma Co Ltd - Key Employee Biographies
Sumitomo Dainippon Pharma Co Ltd - Major Products and Services
Sumitomo Dainippon Pharma Co Ltd - History
Sumitomo Dainippon Pharma Co Ltd - Company Statement
Sumitomo Dainippon Pharma Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Sumitomo Dainippon Pharma Co Ltd - Business Description
Business Segment: Other Business
Overview
Performance
Business Segment: Pharmaceuticals Business
Overview
Performance
Geographical Segment: China
Performance
Geographical Segment: Japan
Performance
Geographical Segment: North America
Performance
Geographical Segment: Other Regions
Performance
R&D Overview
Sumitomo Dainippon Pharma Co Ltd - Corporate Strategy
Sumitomo Dainippon Pharma Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Sumitomo Dainippon Pharma Co Ltd - Strengths
Sumitomo Dainippon Pharma Co Ltd - Weaknesses
Sumitomo Dainippon Pharma Co Ltd - Opportunities
Sumitomo Dainippon Pharma Co Ltd - Threats
Sumitomo Dainippon Pharma Co Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sumitomo Dainippon Pharma Co Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Mar 05, 2021: Sumitomo Dainippon Pharma announces posting of Impairment Loss
Mar 04, 2021: Sumitomo Dainippon Pharma earns recognition for the first time in the health & productivity management stock selection
Mar 02, 2021: Sumitomo Dainippon Pharma announces organizational realignment and changes in the positions assumed by executive officers and other key positions
Feb 26, 2021: Sumitomo Dainippon Pharma announces changes of Representative Directors and Executive Officers
Feb 01, 2021: Sumitomo Dainippon Pharma announces investment in a Venture Capital Fund
Jan 28, 2021: Sumitomo Dainippon Pharma: Summary of consolidated financial results for the third quarter of the year ending March 31, 2021
Oct 28, 2020: Sumitomo Dainippon Pharma announces financial results for the second quarter of the year ending March 31, 2021
Aug 05, 2020: Sumitomo Dainippon Pharma, Sompo Japan, and Aikomi announce collaboration on R&D and commercialization of digital devices for Dementia and Nursing Care
May 21, 2020: Sumitovant Biopharma's family of companies achieve multiple clinical and corporate milestones in the first full quarter of Sumitovant's operation
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Sumitomo Dainippon Pharma Co Ltd - Key Facts
Sumitomo Dainippon Pharma Co Ltd - Key Employees
Sumitomo Dainippon Pharma Co Ltd - Key Employee Biographies
Sumitomo Dainippon Pharma Co Ltd - Major Products and Services
Sumitomo Dainippon Pharma Co Ltd - History
Sumitomo Dainippon Pharma Co Ltd - Company Statement
Sumitomo Dainippon Pharma Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Sumitomo Dainippon Pharma Co Ltd - Business Description
Business Segment: Other Business
Overview
Performance
Business Segment: Pharmaceuticals Business
Overview
Performance
Geographical Segment: China
Performance
Geographical Segment: Japan
Performance
Geographical Segment: North America
Performance
Geographical Segment: Other Regions
Performance
R&D Overview
Sumitomo Dainippon Pharma Co Ltd - Corporate Strategy
Sumitomo Dainippon Pharma Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Sumitomo Dainippon Pharma Co Ltd - Strengths
Sumitomo Dainippon Pharma Co Ltd - Weaknesses
Sumitomo Dainippon Pharma Co Ltd - Opportunities
Sumitomo Dainippon Pharma Co Ltd - Threats
Sumitomo Dainippon Pharma Co Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sumitomo Dainippon Pharma Co Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Mar 05, 2021: Sumitomo Dainippon Pharma announces posting of Impairment Loss
Mar 04, 2021: Sumitomo Dainippon Pharma earns recognition for the first time in the health & productivity management stock selection
Mar 02, 2021: Sumitomo Dainippon Pharma announces organizational realignment and changes in the positions assumed by executive officers and other key positions
Feb 26, 2021: Sumitomo Dainippon Pharma announces changes of Representative Directors and Executive Officers
Feb 01, 2021: Sumitomo Dainippon Pharma announces investment in a Venture Capital Fund
Jan 28, 2021: Sumitomo Dainippon Pharma: Summary of consolidated financial results for the third quarter of the year ending March 31, 2021
Oct 28, 2020: Sumitomo Dainippon Pharma announces financial results for the second quarter of the year ending March 31, 2021
Aug 05, 2020: Sumitomo Dainippon Pharma, Sompo Japan, and Aikomi announce collaboration on R&D and commercialization of digital devices for Dementia and Nursing Care
May 21, 2020: Sumitovant Biopharma's family of companies achieve multiple clinical and corporate milestones in the first full quarter of Sumitovant's operation
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Sumitomo Dainippon Pharma Co Ltd, Key Facts
Sumitomo Dainippon Pharma Co Ltd, Key Employees
Sumitomo Dainippon Pharma Co Ltd, Key Employee Biographies
Sumitomo Dainippon Pharma Co Ltd, Major Products and Services
Sumitomo Dainippon Pharma Co Ltd, History
Sumitomo Dainippon Pharma Co Ltd, Other Locations
Sumitomo Dainippon Pharma Co Ltd, Subsidiaries
Sumitomo Dainippon Pharma Co Ltd, Key Competitors
Sumitomo Dainippon Pharma Co Ltd, Ratios based on current share price
Sumitomo Dainippon Pharma Co Ltd, Annual Ratios
Sumitomo Dainippon Pharma Co Ltd, Annual Ratios (Cont...1)
Sumitomo Dainippon Pharma Co Ltd, Annual Ratios (Cont...2)
Sumitomo Dainippon Pharma Co Ltd, Interim Ratios
Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sumitomo Dainippon Pharma Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Sumitomo Dainippon Pharma Co Ltd, Key Facts
Sumitomo Dainippon Pharma Co Ltd, Key Employees
Sumitomo Dainippon Pharma Co Ltd, Key Employee Biographies
Sumitomo Dainippon Pharma Co Ltd, Major Products and Services
Sumitomo Dainippon Pharma Co Ltd, History
Sumitomo Dainippon Pharma Co Ltd, Other Locations
Sumitomo Dainippon Pharma Co Ltd, Subsidiaries
Sumitomo Dainippon Pharma Co Ltd, Key Competitors
Sumitomo Dainippon Pharma Co Ltd, Ratios based on current share price
Sumitomo Dainippon Pharma Co Ltd, Annual Ratios
Sumitomo Dainippon Pharma Co Ltd, Annual Ratios (Cont...1)
Sumitomo Dainippon Pharma Co Ltd, Annual Ratios (Cont...2)
Sumitomo Dainippon Pharma Co Ltd, Interim Ratios
Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sumitomo Dainippon Pharma Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Sumitomo Dainippon Pharma Co Ltd, Performance Chart (2017 - 2021)
Sumitomo Dainippon Pharma Co Ltd, Ratio Charts
Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Sumitomo Dainippon Pharma Co Ltd, Performance Chart (2017 - 2021)
Sumitomo Dainippon Pharma Co Ltd, Ratio Charts
Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021